Psoriasis can increase skin infection risk due to effects from the condition and its treatments. Learn about potential infections, symptoms, and preventive measures.

Having itchy skin can be a sign of anything from irritating clothing to eczema, but an oncologist has warned that your ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and ...

Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...

Persistent itching can sometimes signal serious illness, including cancer. Oncologist Dr Amit Garg highlights four ...

An oncologist has warned that feeling itchy could be a symptom of four different types of cancer, and it's important to know ...

Learn what collagen is, why it may or may not have benefits for psoriasis, according to experts, and what the research has found so far.

Itchy skin is a common thing we all experience from time to time, but one oncologist has warned that in some cases it could ...

Alumis, a clinical-stage biopharmaceutical company, has announced two phase 3 trials of its TYK2 inhibitor envudeucitinib met their co-primary endpoints in adults with moderate to severe plaque ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and greater patient access to advanced therapies. The shift from conventional ...